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We have purified to homogeneity a 15 kDa-protein from a ribosomal salt extract of Escherichia coli that compensates in vitro a defect of SecA 
but not of SecB. Removal of this protein from a cell-free transcription/translation system impairs translocation into plasma membrane vesicles 
of the precursors of LamB and to a lesser degree also of OmpA. These results suggest a role of the 15 kDa-protein in bacterial protein export. 
The NH,-terminal 35 amino acids were found to be identical to those of the skp (firA) gene product, to which several putative functions have 
previously been attributed. 
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1. INTRODUCTION 
A number of proteins have been identified both 
genetically and biochemically as being involved in pro- 
tein export in E. coli (recently reviewed in [l]). The 
more intensively studied of these include SecA [ 11, SecB 
[ 11, SecY [ 11, trigger factor [l] GroEL and GroES [ 1,2]. 
1.6 cm) using buffer B. Eluted proteins were identified by SDS- 
PAGE. Fractions containing most of the 15 kDa-protein were pool- 
ed, concentrated by centrifugal ultrafiltration and diluted 40-fold in- 
to pH 9.5-buffer (50 mM Tris base, 50 mM KOAc, 15 mM 
Mg(OAc)2,1 mM DTT, adjusted to pH 9.5 at 8°C with acetic acid). 
The protein solution was applied to 10 ml CM-Sepharose CL-6B 
equilibrated at pH 9.5 and proteins were eluted using a 50-300 mM 
K+-gradient prepared in pH 9.5-buffer. 
Here we describe the purification and characteriza- 
tion of a soluble E. coli protein which we identified by 
its stimulating activity on protein transport into plasma 
membrane vesicles. This protein appears to be identical 
to a protein that has previously been reported to fulfill 
quite different functions such as (1) DNA-binding; (2) 
interaction with RNA-polymerase; (3) lipopoly- 
saccharide-binding. 
2.2. Various methods 
Published procedures were employed for quantitative determina- 
tion of radioactivity present in bands on SDS-gels [5], in vitro syn- 
thesis and translocation of LamB [6], preparation of an anti-15 kDa 
protein IgG column [7], and removal of the 15 kDa protein from an 
S-135 [S]. 
3. RESULTS AND DISCUSSION 
2. MATERIALS AND METHODS 
2.1. Purification of the 15 kDa-protein 
E. coli cells from 4-6 1 cultures of strains MM18 [3] or MRE600 
[4] were broken in a French pressure cell at 55 MPa and an S-30 was 
prepared [4]. Ribosomes from the S-30 were collected by centrifuga- 
tion (Beckman Instruments, Ti 50.2 rotor; 45,000 rpm for 2.5 h), ex- 
tracted in 25 m1 buffer A (50 mM triethanolamine acetate (TeaOAc) 
pH 7.5, 15 mM Mg(OAc)z, 1 mM DTT) containing 1 M KOAc and 
re-centrifuged. The ribosomal salt extract, dialyzed overnight against 
3 x 1 liter buffer B (buffer A containing 50 mM KOAc), was applied 
to 15 ml packed DEAE-Sepharose CLdB (Pharmacia) equilibrated 
with buffer B. The flow through was loaded onto 10 ml CM- 
Sepharose CLdB (Pharmacia) equilibrated with buffer B, and bound 
proteins were eluted with buffer C (buffer A containing 220 mM 
KOAc). The eluate was concentrated by centrifugal ultrafiltration 
and further resolved on a Sephacryl S-360 (Pharmacia)-column (85 x 
We have previously shown that the precursor of the 
outer membrane protein LamB is translocated into 
plasma membrane vesicles with considerably reduced 
efficiency if the E. cofi cell extract used for in vitro syn- 
thesis (S-135) is prepared from SecA-deficient mutant 
cells [a]. This translocation defect can be overcome by 
supplementing the SecA-protein [6]. Unexpectedly, 
SecA-free subfractions derived from a ribosomal salt 
extract also restored translocation to .secA-mutant 
S-135s. This finding is illustrated in Fig. 1. 
Correspondence address: M. Miiller, Biochemisches Institut der 
Universitat, Hermann-Herder-Str. 7, D-7800 Freiburg, FRG 
Abbreviations: INV, inverted plasma membrane vesicles; K-INV, 
salt-extracted INV. 
A ribosomal salt extract prepared from se4 wild- 
type cells was subfractionated as detailed in Materials 
and Methods. Fig. IA shows the protein pattern 
resulting from SDS-PAGE of fractions collected from 
the Sephacryl column (lanes 1 to 7). Aliquots of the 
fractions 2-7 were added to secA mutant-derived, cell- 
free translocation reactions. Fig. lB, C shows “S- 
labeled translationkranslocation products of LamB 
resolved by SDS-PAGE and visualized by 
fluorography. Translocation into salt-extracted, in- 
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Fig. 1. Purification by gel filtration of an activity capable of compen- 
sating the SecA-defect in vitro. A ribosomal salt extract was frac- 
tionated as described in the text. Aliquots of fractions (lanes l-7) 
eluting from the Sephacryl S-300 column were analyzed as follows. 
(A) SDS-PAGE and staining with Coomassie blue. Lane 8 shows the 
purified 15 kDa protein after re-chromatography on CM-Sepharose 
at pH 9.5. Migration of molecular weight standards is indicated in 
kDa. The arrow points to the 15 kDa protein. (B) Influence of added 
fractions on the proteolytic processing of preLamB p) to LamB (D) 
by cotranslationally added K-INV. PreLamB was synthesized by an 
S-135 prepared from the secA-mutant strain MM52 [3] grown at 
42°C [a]. The K-INV were derived from a secA+-strain. CO 
represents a control reaction to which elution buffer was added. The 
percentage processing, calculated as [cpm in LamB/(cpm in preLamB 
+ cpm in LamB)] x 100, is indicated. (C) The portions of LamB- 
species hown in panel B, that are resistant o proteinase K [a]. 
verted membrane vesicles (K-INV) is indicated by the 
proteolytic conversion of preLamB to mature LamB 
(Fig. lB, closed and open arrowhead, respectively) and 
by the protease resistance acquired after translocation 
into the vesicles (Fig. 1C). Quantitation of the pro- 
teolytic processing is indicated below panel B. The low 
processing and translocation of preLamB into K-INV, 
inherent in the secA-mutant system (Fig. 1B and C, co), 
are considerably stimulated by the two fractions shown 
in lanes 4 and 5. These fractions coincide with the peak 
elution of a 15 kDa protein (Fig. lA, arrow). 
The translocation-stimulating activity further 
copurified with the 15 kDa protein during subsequent 
chromatography on CM-Sepharose at pH 9.5, yielding 
a homogenous preparation of this protein (Fig. lA, 
lane 8). On isoelectric focusing the 15 kDa protein turn- 
ed out to be a basic protein with an isoelectric point of 
approximately 10 (not shown). 
To confirm that the 15 kDa protein, which can at 
least partially substitute for the 100 kDa SecA, and 
SecA are in fact unrelated proteins, their antigenic 
crossreactivities were examined. Polyclonal antibodies 
against the purified 15 kDa protein were raised in mice. 
They are largely monospecific as shown by im- 
munoblotting of several crude subcellular fractions 
(Fig. 2). As expected, the antibodies recognize the 
purified 15 kDa protein (lane 4) but do not crossreact 
with SecA (lane 7). Vice versa, anti-SecA-antibodies do 
not recognize the 15 kDa protein (not shown). 
Moreover, 15 kDa protein cross-reacting material is 
detected in S-135s containing both wild-type- (lanes 8 
and 10) and mutant-SecA (lane 9). This result rules out 
the possibility that the 15 kDa protein stimulates 
translocation in SecA-deficient S-135s because it is ab- 
sent from these extracts. 
The antibodies were further used to examine the 
distribution of the 15 kDa antigen among several 
subcellular fractions. It is a soluble protein found in the 
postribosomal supernatant (Fig. 2, lane I), the 
ribosomal fraction (lane 2), the ribosomal salt extract 
(lane 3) and, to a lesser degree, associated with the 
plasma membranes (INV, lane 5), from which it can be 
removed by high-salt treatment (K-INV, lane 6). 
We then addressed whether manifestation of the 
stimulating activity of the 15 kDa protein on the 
translocation of preLamB into K-INV was dependent 
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Fig. 2. The 15 kDa-protein is not antigenically related to SecA and 
is found in various subcellular fractions. Immunoblotting using 
polyclonal anti-15 kDa-antibodies was carried out for the following 
subcellular fractions of E. coli. Lane 1: 5 ~1 of a postribosomal super- 
natant (S-150); 2: equivalent amount of ribosomes; 3: equivalent 
amount of ribosomal salt extract; 4: 2 pg of pure 15 kDa-protein; 5: 
6 ~1 of INV; 6: 8 ~1 of K-INV; 7: 0.3 kg of pure SecA (generous gift 
from Dr. William Wickner); 8: 4 ~1 of S-135 from strain MM52 
grown at 30°C (secA+); 9: 4 pl of S-135 from strain MM52 grown 
at 42°C (secA_); 10: 4 ~1 of S-135 from strain MZ9 [4] (secA +). 
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on a reduction in the translocation capacity of the cell- 
free system. Whereas the purified 15 kDa-protein clear- 
ly compensates in part for a SecA-deficiency (Fig. 3, 
lanes 1 and 2) it does not compensate for a lack of SecB 
(lanes 3 and 4). Furthermore, addition of the 15 kDa- 
protein also increases the translocation efficiency of a 
secA and secB wild-type cell-free system (not shown), 
albeit to a lesser degree than in the secA-mutant system. 
To demonstrate an involvement of the 15 kDa- 
protein in protein export independent of the level of 
SecA, anti-15 kDa-protein-IgGs were cross-linked to 
protein A-Sepharose and this matrix was used to 
remove the 15 kDa-protein from a SecA-containing 
S-135. A control (mock-depleted) S-135 was prepared 
using a matrix to which preimmune IgGs had been 
coupled. As demonstrated in Fig. 3, lane 7, removal of 
the 15 kDa-protein reduces processing of preLamB by 
K-INV when compared to the mock-treated control 
(lane 6) and the untreated sample (lane 5). Quantitation 
of the data obtained in 6 independent experiments 
reveals an average reduction of processing by 39% + 
6 (with the translocation efficiency of the mock-treated 
control being set at 100%). As expected, addition of the 
15 kDa protein partially reverses this effect, regaining 
74 + 9% of the translocation efficiency (not shown). 
Moreover, a decrease in processing due to a removal of 
the 15 kDa-protein was not restricted to LamB. An 
S-135 depleted of the 15 kDa protein also gives rise to 
a diminished processing (80%) of the precursor of Om- 
pA (not shown). 
When the purified 15 kDa protein was subjected to 
automated Edman degradation the following sequence 
of the 35 NHz-terminal amino acid residues was ob- 
tained: Ala-Asp-Lys-Ile-Ala-Ile-Val-Asn-Met-Gly-Ser- 
Leu-Phe-Gln-Gln-Val-Ala-Gln-Lys-Thr-Gly-Val-Ser- 
Asn-Thr-Leu-Glu-Am-Glu-Phe-Lys-Gly-Arg-Ala-Ser. 
This sequence is identical to the first 35 residues of the 
Skp (FirA)-protein [9-l 11) of E. coli, and shows over 
90% sequence identity to OmpH of Salmonella 
typhimufium [ 121. 
The @A-locus was originally defined by ts- 
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Fig. 3. Involvement of the 15 kDa-protein in translocation of 
preLamB into K-INV. PreLamB was synthesized in vitro in the 
presence of K-INV using and S-135 from the se&-mutant MM52 
(lanes 1,2,8,9), from the secB-mutant CK1953 1211 (lanes 3 and 4). or 
from the secA + -strain MZ9, (lane 5). The reactions hown in lanes 
6 and 7 were directed by an MZ9-derived S-135 that had been passed 
over a preimmune (lane 6) or an anti-15 kDa-protein (lane 7) im- 
munoaffinity column. Processing of preLamB to LamB was quan- 
titated and is indicated in 070. Reactions shown in lanes 2 and 4 had 
received 0.5 cg of purified 15 kDa protein each; that of lane 9 0.125 
pg histone H2B (Sigma). 
mutations that both render RNA synthesis thermosen- 
sitive and eliminate resistance to rifampicin, which is 
conferred by mutations of the RNA polymerase /3 gene 
[ 131. The gene product of firA displaying histone-like 
properties (designated HLP-I) was proposed to interact 
directly with RNA polymerase [141. Subsequently, FirA 
was shown to be identical [15] to the 17 kDa-protein 
(Skp) which had been identified and purified as consti- 
tuent of the E. coli nucleoid [9]. The firA gene maps at 
the 4 min region on the chromosome and is located im- 
mediately upstream of genes that encode proteins in- 
volved in lipid A biosynthesis [lo]. 
How can these properties of Skp (FirA) be related to 
our finding of an involvement in protein export? (1) 
The excess of positively charged amino acids explains 
well why Skp (FirA) sticks to polyanions such as DNA 
and ribosomes. However, it is unlikely that the cationic 
character of Skp (FirA) is the basis of its functioning in 
protein export. A different cationic protein, eukaryotic 
histone H2B, whose amino acid composition resembles 
that of the more typical histone-like protein HU of E. 
coli [cf. 161, did not stimulate translocation into K-INV 
when preLamB was synthesized in a SecA-deficient 
cell-free system (Fig. 3, lanes 8 and 9). This result was 
obtained with the highest possible concentration of 
H2B not abolishing in vitro synthesis, which was in the 
same order of magnitude as the concentration of Skp 
(FirA) required for activity. (2) Skp (FirA) does not af- 
fect translocation by influencing the rate of synthesis. 
Such an interrelationship is suggested by a previous 
report describing the suppression of a SecA-defect in 
vivo by various measures slowing down protein syn- 
thesis [17]. Skp, however, does not influence transcrip- 
tion in vitro [9]. Moreover, determination of a time 
course of LamB synthesis in vitro revealed that the ad- 
dition to a secA-mutant S- 135 of the 15 kDa-protein we 
isolated does not change the amount of preLamB and 
LamB synthesized at any time point, but only increases 
the percentage of processed LamB (not shown). 
Surprisingly, the nucleotide sequence of skp disclos- 
ed the existence of an NHz-terminal signal sequence [8] 
which had been removed from the mature protein 
purified in this and other laboratories. The meaning of 
this finding is not clear [15] particularly because this 
protein is found in several different subcellular 
fractions. 
Recently Skp (FirA) was found to be homologous to 
OmpH, a protein associated with the outer membrane 
of S. typhimurium [12,181. OmpH in turn appears to be 
related to a lipopolysaccharide-binding protein 
detected in various Enterobacteriaceae [19]. It is con- 
ceivable that the soluble Skp (FirA), due to its basic net 
charge, sticks to the outer membrane, as well as to 
other cell costituents, upon breakage of the bacteria 
cells. On the other hand, the existence of a signal se- 
quence appears to suggest a location in the cell 
envelope. 
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At the present time it is difficult to reconcile all the 
diverse properties of Skp (FirA) deduced from its 
association with distinct celh.thir components with the 
activity of a sing#e protein. Clearly, the only fun~iona~ 
analyses of this protein are those of the f&A-mutants 
and the one described herein. Our results uggest arole 
of Skp (FirA) in the export of outer membrane pro- 
teins. If this function is of a more general nature like 
that of chaperonins [XI], conferring tra~s~o~t~on~ 
~orn~te~~ by directly interacting with export pro- 
teins, it migbt even explain how Skp (FirA) could be ac- 
tive on either side of the plasma membrane of E, coli. 
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Note @4&&d after ~~~~~~~ af the ~~~~~~~~t: In contrast to 
previous reports ft5]$rA and skp have recently been found to be dif- 
ferent gene loci and the Skpprotein does not complement he firA- 
phenotype (I, Dicker, personal communication). Thus, the sequence 
of the IS k&t protein described herein, is identical only to that of the 
Skp-protein. 
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